Endpoints News names Sangeeta Bhatia one of 20 women reshaping biopharma in 2023 her efforts to help women in academia launch startups

(Endpoint News) It’s easy to forget that change takes time.

Drugmakers and industry organizations have launched a wave of diversity, equity and inclusion efforts over the last decade, but in some respects, it seems like the needle has barely budged. Women remain vastly underrepresented across biotech’s highest ranks, and recent data suggest slow progress.

Until you meet some of the women leading the push. They’ve created their own networks, empowered other female leaders to launch companies, filed court briefs and spoken up against injustices. They’re also behind some of the industry’s most cutting-edge science, finding new applications for mRNA, working through solutions to cell therapy’s greatest challenges, reviving underserved areas like antibiotics and women’s health, and exploring new frontiers in diagnostics and decentralized trials. Their contributions to medicine and to the women of future generations are immeasurable.